EUVIMEDEUVIMED entdecken
Crossref

Recurrence rate and management after endoscopic papillectomy in a tertiary referral center

Lorenzo Dioscoridi, Durante Donnarumma, Edoardo Forti, Francesco Pugliese, Marcello Cintolo, Giulia Bonato, Marianna Bravo, Andrea Palermo, Massimiliano Mutignani

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2024.04.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Lorenzo Dioscoridi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Digestive and Interventional Endoscopy, ASST GOM Niguarda, Milan, Italy. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Tertiary Care Centers, Adenoma, Ampulla of Vater. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND STUDY AIMS: Endoscopic papillectomy (EP) is considered a safe procedure for ampullary lesions. Few data are available on management of residual and recurrent adenomas. The aims of the present study were to evaluate long-term recurrence rate, median time-to-recurrence after EP and treatment of both residual and recurrent adenomas. PATIENTS AND METHODS: Consecutive patients who underwent EP of major and minor papilla at our endoscopy center between 2011 and 2022 were enrolled. Residual adenoma was defined as the endoscopic evidence of adenomatous tissue after EP. Recurrent adenoma was defined as the presence of adenomatous tissue after the first endoscopic follow-up and complete adenoma resection. RESULTS: 95 patients satisfied the inclusion criteria. Pathology after resection showed adenoma with low-grade dysplasia (LGD) in 52 patients, high-grade dysplasia (HGD) in 25 patients, adenocarcinoma in 6 patients, NET in 4 patients and not-neoplastic duodenal mucosa in 8 patients. Adverse events occurred in 25 % of patients. The median follow-up after EP was 22.5 months. Local residual was observed in 27 patients (28,4 %) and recurrence after the endoscopic retreatments occurred in 11 patients (11,6 %). Furthermore, recurrence occurred in 16 of 68 patients with adenoma-free after a first endoscopic follow-up and 9 patients developed at least a second recurrence. All the recurrences but one were endoscopically treated. CONCLUSIONS: EP and its ancillary treatments for residual and recurrent adenomas is an effective treatment for ampullary tumors. Long-term surveillance demonstrates that recurrences can be mainly treated endoscopically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalTertiary Care CentersAdenomaAmpulla of VaterCommon Bile Duct NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesSphincterotomy, EndoscopicAdultAged, 80 and over

Stichwörter der Autor:innen

AmpullomaERCPEndoscopic papillectomyIntraductal radiofrequencyPapillary neoplasm

Autor:innen und Institutionen

  • Digestive and Interventional Endoscopy, ASST GOM Niguarda, Milan, Italy.
  • Digestive and Interventional Endoscopy, ASST GOM Niguarda, Milan, Italy. Electronic address: massimiliano.mutignani@ospedaleniguarda.it.

Zitieren

APA

Dioscoridi, L., Donnarumma, D., Forti, E., Pugliese, F., Cintolo, M., Bonato, G., Bravo, M., Palermo, A., & Mutignani, M. (2024). Recurrence rate and management after endoscopic papillectomy in a tertiary referral center. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.04.037

Vancouver

Dioscoridi L, Donnarumma D, Forti E, Pugliese F, Cintolo M, Bonato G, et al. Recurrence rate and management after endoscopic papillectomy in a tertiary referral center. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.04.037

BibTeX
@article{Dioscoridi2024,
  author = {Dioscoridi, Lorenzo and Donnarumma, Durante and Forti, Edoardo and Pugliese, Francesco and Cintolo, Marcello and Bonato, Giulia and Bravo, Marianna and Palermo, Andrea and Mutignani, Massimiliano},
  title = {Recurrence rate and management after endoscopic papillectomy in a tertiary referral center},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2024.04.037}
}
Kostenlos starten →